
Our medical experts are ready to answer your questions and guide you through your treatment options.
For Bangladesh couples facing genetic health concerns, the path to parenthood can bring unique anxieties. Ensuring a healthy future often involves advanced options like PGT-A/PGT-M, yet accessing quality care and understanding the process poses significant worries.
Many families from Bangladesh seek specialized care abroad for advanced embryo genetic testing. Pune, with its robust medical infrastructure and collaborative healthcare environment, has become a preferred city for such intricate diagnostic procedures.
Pune’s medical community offers experienced fertility specialists and embryologists specializing in PGT-A/PGT-M. Hospitals here provide a supportive setting, ensuring smooth coordination for tests, procedures, and follow-up within the city for international patients.
Pune offers a comprehensive and accessible option for PGT-A/PGT-M, combining expertise with patient-focused care.
PGT-A/PGT-M (Preimplantation Genetic Testing of Embryos) screens embryos from In Vitro Fertilization (IVF) for genetic issues. PGT-A detects chromosomal abnormalities (like missing or extra chromosomes) that can cause implantation failure or conditions like Down syndrome. PGT-M identifies specific inherited single gene disorders (e.g., cystic fibrosis, sickle cell anemia) known to be present in parents. Both tests aim to select healthy embryos, significantly improving pregnancy success rates and reducing the risk of transmitting known genetic conditions.
PGT-A (Preimplantation Genetic Testing for Aneuploidy): Screens for an abnormal number of chromosomes in embryos.
PGT-M (Preimplantation Genetic Testing for Monogenic/Single Gene Defects): Identifies specific inherited single gene disorders.
PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements): Detects chromosomal structural changes like translocations or inversions.
Embryo Biopsy: The delicate process of removing a few cells from the blastocyst stage embryo for genetic analysis.
Next-Generation Sequencing (NGS): The primary technology used to analyze biopsied cells for genetic abnormalities.
The PGT-A/PGT-M process is integrated with an IVF cycle, spanning from ovarian stimulation to embryo transfer, with the genetic testing component conducted in the laboratory.
The female partner receives medications to stimulate egg production. Mature eggs are then retrieved via a minor surgical procedure.
Retrieved eggs are fertilized with sperm in the lab using IVF or ICSI. Resulting embryos are cultured for five to six days until they reach the blastocyst stage.
Highly skilled embryologists carefully remove a few cells from the trophectoderm (outer layer) of each viable blastocyst. This is performed with precision to minimize impact on the embryo.
The biopsied cells are sent to a specialized genetics laboratory for PGT-A or PGT-M analysis. The remaining embryos are cryopreserved (frozen) while awaiting results.
Once genetic test results are available, healthy embryos free of detected abnormalities are selected and transferred into the uterus. This is a simple, non-surgical procedure.
Patients receive guidance on post-transfer care, including medication protocols and activity recommendations, leading up to a pregnancy test.
Recovery largely relates to the IVF stages. After egg retrieval, patients might experience mild discomfort or bloating for a few days. Post-embryo transfer, a period of rest and avoiding strenuous activities is advised to aid implantation. There is no direct physical recovery from the genetic testing itself, as it is performed on the embryos in the lab. Patients receive specific instructions, medication protocols, and follow-up schedules designed to support embryo implantation and early pregnancy.
PGT-A/PGT-M significantly boosts pregnancy rates per embryo transfer and reduces miscarriage rates by ensuring only chromosomally normal or genetically healthy embryos are selected. For PGT-M, it substantially lowers the chance of having a child with the specific genetic disorder being screened for. Success rates depend on various factors including maternal age, underlying fertility issues, the number of embryos available, and the expertise of the clinic. Patients should have a detailed discussion with their fertility specialist to understand their individual prognosis and realistic expectations.
The cost of PGT-A/PGT-M in Pune varies based on several factors, including the chosen fertility clinic, the specific genetic testing type (PGT-A or PGT-M), the number of embryos biopsied and analyzed, and the associated overall IVF cycle costs.
Generally, the cost for PGT-A/PGT-M in Pune can range from INR 1,50,000 to INR 3,50,000, excluding the base IVF cycle cost.
Pune offers a significant cost advantage for advanced genetic testing compared to many Western countries, without compromising on quality or technology.
| Location | Estimated Cost (USD) |
|---|---|
| Pune, India | $2,000 - $4,500 |
| United States | $4,000 - $10,000 |
| United Kingdom | $3,500 - $8,000 |
| Australia | $3,000 - $7,000 |
| Thailand | $2,500 - $5,500 |
Ready to explore PGT-A/PGT-M options in Pune?
Contact our patient support team for personalized guidance and cost estimates.
Have questions about PGT-A/PGT-M in Pune?
Connect with our expert team to get answers and begin your journey.
Choosing PGT-A/PGT-M is a significant decision on your path to parenthood. Pune offers a blend of advanced medical care, experienced specialists, and compassionate support to guide you through this journey with confidence.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.